Qube Gains ASX Approval for Scheme Timetable Change and Dividend Payment

Qube Holdings has obtained an ASX waiver allowing it to deviate from the standard scheme of arrangement timetable, enabling a fully franked special dividend payment and accommodating bidder funding arrangements. The board unanimously recommends shareholder approval, contingent on independent expert support and absence of superior proposals.

  • ASX grants waiver for scheme timetable modifications
  • Special dividend payment planned post-scheme effectiveness
  • Board unanimously backs scheme absent superior offers
  • Scheme meetings expected in June following court hearing
  • Dividend franking credits add potential shareholder value
An image related to Qube Holdings Limited
Image source middle. ©

ASX Waiver Enables Flexible Scheme Timing and Dividend

Qube Holdings Limited (ASX:QUB) has secured a crucial waiver from ASX Listing Rule 7.40, allowing the company to implement its proposed scheme of arrangement on a timetable that diverges from the standard prescribed schedule. This adjustment is designed to facilitate the payment of a fully franked special dividend after the scheme becomes effective, subject to the discretion of the Qube board.

The waiver also accommodates the bidder, Rubik Australia Pty Limited, in drawing down funds to pay the cash consideration under the scheme. ASX’s conditional approval underscores the importance of clear market disclosure regarding the impact on investors trading shares post-scheme effective date, and any further timetable changes require ASX’s prior consent.

Dividend Strategy Adds Value Amid Acquisition

The proposed special dividend, fully franked, represents an additional value layer for eligible shareholders able to utilise the franking credits. While the decision to declare and pay the dividend rests solely with the Qube board, the move is consistent with the terms agreed in the scheme implementation deed with Rubik Australia. This dividend strategy could appeal particularly to investors seeking tax-effective income streams from their holdings.

Board Support and Upcoming Shareholder Engagement

Qube’s board unanimously recommends shareholders vote in favour of the scheme, provided no superior proposal emerges and an independent expert continues to affirm the scheme’s benefits to shareholders other than UniSuper. Each director intends to vote their shares in favour, signalling strong internal alignment behind the deal.

Following the upcoming court hearing on 23 April 2026, Qube plans to dispatch notices of meeting and the scheme booklet to shareholders ahead of the court-convened meetings anticipated in June. This timeline adjustment aligns with the ASX waiver and reflects a carefully managed process to balance shareholder communication and transaction execution.

This development follows Qube’s recent disclosure of earnings pressures from geopolitical and weather-related disruptions, which have not derailed the scheme process despite introducing some financial uncertainty. The company’s ability to maintain momentum on the scheme amid these challenges highlights robust deal management and strategic focus.

For further insight into Qube’s financial backdrop and operational resilience amid external shocks, see the detailed discussion of the company’s $13-$25 million FY26 earnings hit and its implications for the scheme.

Bottom Line?

Qube’s ASX waiver and special dividend plan add complexity to the scheme timetable, making shareholder scrutiny and upcoming court outcomes pivotal.

Questions in the middle?

  • Will the Qube board declare the special dividend and how might this influence shareholder voting?
  • Could any superior proposal emerge to disrupt the current scheme arrangement?
  • How will the adjusted timetable affect investor trading behaviour and market liquidity ahead of scheme completion?